WG
MRVI icon

Winton Group’s Maravai LifeSciences MRVI Stock Holding History

Winton Group’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$604K Buy
+96,800
New +$418K 0.02% 647
2024
Q1 		– Sell
-25,804
Closed -$169K – 779
2023
Q4 		$169K Sell
25,804
-4,185
-14% -$27K 0.01% 659
2023
Q3 		$300K Buy
29,989
+3,279
+12% +$36K 0.02% 552
2023
Q2 		$332K Buy
26,710
+6,599
+33% +$89.1K 0.03% 493
2023
Q1 		$282K Buy
+20,111
New +$289K 0.02% 832
2022
Q1 		– Sell
-11,167
Closed -$468K – 1089
2021
Q4 		$468K Buy
+11,167
New +$452K 0.03% 693

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Winton Group's MRVI Position: Q2 2026 in Review

Winton Group opened a new position in Maravai LifeSciences (MRVI) in Q2 2026: 96,800 shares worth $604K. The stake represents 0.02% of the portfolio and ranks #647 among its holdings. This is a return to the name: Winton Group previously reported a position in MRVI as recently as Q4 2023.

Winton Group first reported a position in MRVI in Q4 2021 and has held it in 6 quarters since. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Winton Group held 96,800 shares of Maravai LifeSciences worth $604K as of Q2 2026.
  • Maravai LifeSciences was a new Winton Group position in Q2 2026.
  • Maravai LifeSciences made up 0.02% of Winton Group's portfolio in Q2 2026, its #647 holding.
  • Winton Group first reported a position in Maravai LifeSciences in Q4 2021 and has held it in 6 quarters since.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.